Sivik Global Healthcare LLC Neurocrine Biosciences Inc Transaction History

Sivik Global Healthcare LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$75.79 - $100.07 $1.71 Million - $2.25 Million	-22,500 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$72.45 - $94.81 $1.63 Million - $2.13 Million	22,500 New	22,500 $2.11 Million
Q3 2019 Nov 12, 2019	SELL	$83.82 - $101.5 $3.35 Million - $4.06 Million	-40,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$72.24 - $91.27 $2.89 Million - $3.65 Million	40,000 New	40,000 $3.38 Million
Q2 2018 Aug 06, 2018	SELL	$75.3 - $105.99 $2.26 Million - $3.18 Million	-30,000 Closed	0 $0
Q1 2018 May 08, 2018	SELL	$75.88 - $92.43 $379,400 - $462,150	-5,000 Reduced 14.29%	30,000 $2.49 Million
Q4 2017 Feb 08, 2018	BUY	$58.53 - $77.59 $292,650 - $387,950	5,000 Added 16.67%	35,000 $2.72 Million
Q3 2017 Nov 08, 2017	BUY	$47.97 - $61.28 $1.44 Million - $1.84 Million	30,000	30,000 $1.84 Million

625

94.2M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Sivik Global Healthcare LLC, based on Form 13F filings with the SEC.

Stay updated on Sivik Global Healthcare LLC with notifications on news.